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Antiretroviral therapy fails to cure HIV-1 infection
because latent proviruses persist in resting CD4+
T cells. T cell activation reverses latency, but <1%
of proviruses are induced to release infectious virus
after maximum in vitro activation. The noninduced
proviruses are generally considered defective but
have not been characterized. Analysis of 213 nonin-
duced proviral clones from treated patients showed
88.3% with identifiable defects but 11.7% with intact
genomes and normal long terminal repeat (LTR) func-
tion. Using direct sequencing and genome synthesis,
we reconstructed full-length intact noninduced pro-
viral clones and demonstrated growth kinetics com-
parable to reconstructed induced proviruses from
the same patients. Noninduced proviruses have un-
methylated promoters and are integrated into active
transcription units. Thus, it cannot be excluded that
theymay become activated in vivo. The identification
of replication-competent noninduced proviruses in-
dicates that the size of the latent reservoir—and,
hence, the barrier to cure—may be up to 60-fold
greater than previously estimated.
INTRODUCTION
Despite prolonged antiretroviral therapy (ART), HIV-1 persists as
transcriptionally inactive proviruses in resting memory CD4+
T cells (Chun et al., 1997; Finzi et al., 1997; Wong et al., 1997).
This latent reservoir (LR) has a long half-life, preventing cure by
ART alone (Finzi et al., 1997; Siliciano et al., 2003; Strain et al.,
2003). In resting CD4+ T cells, the lack of active forms of key
cellular transcription factors (Bo¨hnlein et al., 1988; Duh et al.,
1989; Ganesh et al., 2003; Kinoshita et al., 1997; Nabel and Bal-
timore, 1987; West et al., 2001) and of HIV-1 Tat and its cellular
cofactors (Cujec et al., 1997; Herrmann and Rice, 1995; Jones540 Cell 155, 540–551, October 24, 2013 ª2013 Elsevier Inc.and Peterlin, 1994; Kao et al., 1987; Selby and Peterlin, 1990;
Tyagi et al., 2010) limits the initiation and elongation, respec-
tively, of viral transcription (Lassen et al., 2004; Williams and
Greene, 2007). The LR may thus be established when activated
CD4+ T cells become infected as they revert back to a resting
memory state. In addition, DNA methylation and repressive his-
tonemodifications may silence proviruses (Blazkova et al., 2009;
Coull et al., 2000; He and Margolis, 2002; Kauder et al., 2009;
Van Lint et al., 1996; Verdin et al., 1993; Williams et al., 2006).
A major approach to eradicating HIV-1 involves reversing la-
tency in patients on ART (Richman et al., 2009; Deeks, 2012).
Cells harboring induced proviruses could then be lysed by HIV-
1-specific cytolytic T lymphocytes (CTL) (Shan et al., 2012), while
new rounds of infection are blocked by ART. Clinical trials
exploring this strategy have used the histone deacetylase inhib-
itors (Lehrman et al., 2005; Archin et al., 2009, 2012; Contreras
et al., 2009).
Accurate measurement of the LR is essential for evaluating
eradication strategies. If the LR is eradicated, ART can be dis-
continuedwithout rebound viremia. Interruption before complete
eradication will likely result in rebound (Davey et al., 1999) and
repopulation of the LR.
The standard assay for LR size is a viral outgrowth assay (VOA)
(Finzi et al., 1997; Siliciano and Siliciano, 2005) measuring the
frequency of resting CD4+ T cells that produce infectious virus
after a single round of maximum in vitro T cell activation. Limiting
dilutions of resting CD4+ T cells are stimulated with the mitogen
phytohemagglutinin (PHA), which reverses latency by inducing
T cell activation. Released viruses are expanded by addition of
CD4+ T lymphoblasts from HIV-1-negative donors. Culture
supernatants are examined for exponential viral growth by ELISA
for HIV-1 p24. With this assay, the mean frequency of latently
infected cells in patients on ART is 1/106 resting CD4+ T cells
(Eriksson et al., 2013).
It has been assumed that LR size can be assessed with agents
like PHA that induce uniform T cell activation (Patel et al., 1988;
Hermankova et al., 2003). However, the frequency of latently in-
fected cells detected in the VOA is 300-fold lower than the fre-
quency of resting CD4+ T cells that harbor proviruses detectable
by PCR (Eriksson et al., 2013). Thus, at limiting dilution in the
VOA, negative wells contain many proviruses, which we desig-
nate noninduced proviruses. The noninduced proviruses are
generally considered defective but have not been molecularly
characterized. The magnitude of the challenge presented by
the LR depends on whether noninduced proviruses can be
induced in vivo. We present here a molecular characterization
of noninduced proviruses.
RESULTS
Transwell VOA Achieves Maximum In Vitro Activation
and Outgrowth
To analyze proviruses that did not give rise to infectious virus in
the VOA (noninduced proviruses), we first established that the
conditions were sufficient to activate 100% of resting CD4+
T cells. Resting CD4+ T cells from patients on suppressive ART
for >6monthswere labeledwith carboxyfluorescein succinimidyl
ester (CFSE) and stimulated with PHA and irradiated allogeneic
peripheral blood mononuclear cells (PBMC) under conditions
used in the VOA. By day 7, >99.8% of patient cells had divided
at least once (Figure S1A available online), confirming that PHA
causes uniform T cell activation.
In the VOA, viruses released after reversal of latency replicate
in healthy donor CD4+ lymphoblasts added to the cultures. To
facilitate isolation of noninduced proviruses, we tested whether
comparable levels of activation and viral outgrowth could be
achieved in transwell cultures in which patient cells were sepa-
rated from donor lymphoblasts by a cell-impermeable mem-
brane (Figure S1B). In side-by-side comparison with standard
VOA cultures from ten patients, transwell cultures showed com-
parable cellular activation in both p24+ and p24wells, as >95%
of patient cells expressed human leukocyte antigen-DR (HLA-
DR) and/or CD25 on day 21 (Figure S1C). Transwell cultures
also showed viral outgrowth comparable to standard VOA
cultures (Figure S1D). Noninduced proviruses were thus iso-
lated from p24 wells of limiting dilution transwell and standard
cultures.
Clonal Amplification and Sequencing of Noninduced
Proviruses
We obtained near full-length clonal sequences of noninduced
proviruses from eight patients on suppressive ART. Patient char-
acteristics are in Table S1. Noninduced proviruses were ob-
tained from wells seeded with 4 3 104 or 2 3 105 resting CD4+
T cells that were p24 on day 21. In clonal VOA cultures, wells
with replicating virus are p24+ by days 10–14 (Laird et al.,
2013). Even with a more sensitive real-time (RT)-PCR assay for
HIV-1 mRNA (Laird et al., 2013), none of the p24 wells showed
exponential growth. Thus, the noninduced proviruses were ob-
tained from wells with no replicating virus, despite maximal
T cell activation.
Noninduced proviruses were amplified in limiting dilution
PCRs to avoid in vitro recombination. A near-full-length 9.1 kb
outer PCR (Li et al., 2007) spanning U5 to U5 (positions 623–
9,686, HXB2 coordinates) was followed by nested inner PCRs
(Table S2). Aliquots from outer PCRs were first amplified in a
nested inner gag PCR (Figure 1A). Cell dilutions for which <20%of the inner reactions were positive were selected because
positive wells at these dilutions have >90% probability of being
clonal. Aliquots from the gag+ clonal outer PCRs were amplified
using four sets of inner PCR primers to obtain fragments
overlapping by 150–3,173 base pairs (bp) (Figure 1A). Of note,
instead of cloning PCR products, we directly sequenced
them. This dramatically reduces PCR errors, because errors
occurring after the first or second cycle are present in too
small a fraction of the final products to be observed. Sequences
with double peaks or nonidentical overlap regions were dis-
carded. We identified 213 noninduced proviruses from eight
patients.
Hypermutation and Large Internal Deletions Render
Most Noninduced Proviruses Defective
Most (88.3%) noninduced proviruses had obvious defects pre-
cluding replication (Figure 1C). Direct sequencing of the nested
gag PCR product revealed that1/3 (32.4%) of noninduced pro-
viruses had APOBEC3G-mediated G/ A hypermutation occur-
ring in the expected sequence context (GG or GGG) (Yu et al.,
2004). Hypermutated proviruses are replication defective due
to start codon mutations and numerous tryptophan / stop
codon mutations (Figure S2). Although the gag gene was
analyzed here, other regions of the genome show even greater
hypermutation (Yu et al., 2004). Of note, it is unlikely that hyper-
mutated proviruses could produce functional viral proteins due
to stop codons in most open reading frames (ORFs).
Noninduced proviruses that were not hypermutated were
further analyzed by nested amplification of four overlapping sub-
genomic fragments (Figure 1A). Of the 144 clonal noninduced
proviruseswithout hypermutation, 97 had large internal deletions
identified by smaller amplicon size in electrophoresis (Figure 1B).
We mapped the deletion junctions in 58 of these clones (Fig-
ure 2A). For example, clone 10CB7_48H1 (Figure 1B) gave a
smaller amplicon for the nested C reaction, and amplification
of fragments A, B, and D failed due to deletion of nucleotides
4,869–9,533. All 58 mapped deletions would affect expression
of the essential regulatory proteins Tat and Rev (Figure 2A)
because the deletions encompass the tat and rev exons, the
splice sites, and the Rev-responsive element (RRE).
Deletions are not unexpected. HIV-1 is prone to recombination
due to pseudodiploidity (two RNA copies per virion with physical
proximity for recombination). Frequent template switching
events occur during reverse transcription (Simon-Loriere and
Holmes, 2011). Switching between short repeats in a single-
genome results in deletion of the intervening sequence and
one repeat (Temin, 1993). Large deletions have been observed
in unfractionated PBMC from viremic patients (Sanchez et al.,
1997). Several lines of evidence suggest that these deletions
occur in vivo rather than during in vitro analysis. First, deletions
were observed following direct sequencing of uncloned PCR
products. Second, for a given provirus, the same deletion junc-
tions were observed in different nested PCRs using different
primers. Third, short amplicons were not seen in control experi-
ments with plasmids carrying the reference proviral genomes
NL4-3 and BaL. Plasmids were mixed, diluted to eight copies
per 105 human genome equivalents, and amplified under the
same conditions. No deletion or recombination was observed.Cell 155, 540–551, October 24, 2013 ª2013 Elsevier Inc. 541
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Figure 1. Characterization of Noninduced
Proviruses
(A) Strategy and results of analysis of noninduced
proviruses. Limiting dilution VOA cultures were
established from eight patients. A total of 51 p24
wells containing a total of 8.9 3 106 resting CD4+
T cells were analyzed. Two hundred thirteen non-
induced proviruses were identified by near-full-
length limiting dilution PCR followed by a nested
gag PCR. The gag PCR products were directly
sequenced, and proviruses with APOBEC3G-
mediated G / A hypermutation were identified
using the Los Alamos Hypermut algorithm (Rose
and Korber, 2000). Nonhypermutated proviruses
were analyzed by nested amplification of four
overlapping subgenomic fragments (labeled A–D).
Amplicons with patient HIV-1 sequence but a size
discernibly smaller than expected in 1% agarose
gel electrophoresis were considered to contain
large internal deletions that, where possible, were
mapped by direct sequencing. Other lethal defects
including single-nucleotide insertions and de-
letions (INDELs), packaging signal (J) deletions,
and major splice donor (MSD) site mutations were
identified by direct sequencing.
(B) Results of 1% agarose gel electrophoresis of
four subgenomic amplicons (A–D) from repre-
sentative noninduced proviruses with different
defects. Left to right: intact genome, 16 bp J
deletion, deletion with defined junction, and dele-
tion with undefined junction. Clone name is given
below each gel. Triangles indicate amplicons with
correct size. Asterisks indicate amplicons with a
size smaller than expected.
(C) Summary of the analysis of 213 noninduced
proviruses.
See also Figure S1 and Table S1.Fourth, short sequence repeats were identified at some deletion
junctions (Figure 2B), consistent with a single polymerase jump
due to copy choice recombination during reverse transcription
of the minus strand (Sanchez et al., 1997). Taken together, these
results demonstrate that a large fraction of noninduced provi-
ruses are nonfunctional due to large internal deletions, likely
introduced during reverse transcription.
The precise fraction of proviruses with deletions could be
underestimated by this analysis because deletions could affect
PCR primer binding sites. For 39 clones, the exact deletion junc-
tion could not be identified, probably because the deletions en-
compassed binding sites for primers used in the nested PCRs.
For these clones, we obtained at least two sequences to ensure
that the amplicons contained nonhypermutated, patient-specific
sequences. For 12 mapped deletions, the deletion included the
reverse gag primer binding site, but mapping was possible
because other nested reactions were successful.542 Cell 155, 540–551, October 24, 2013 ª2013 Elsevier Inc.Mutations in cis Elements Render
Some Noninduced Proviruses
Defective
Proviruses with correct amplicon size
were directly sequenced. A small fraction
(8/213) had nonsense mutations and/orframe-shifting insertions or deletions in one or more ORFs. Small
deletions (8–98 bp) were found in the packaging signal (J) in 12
sequences (Figure S3A). The deletions encompassed the major
splice donor (MSD) site. Point mutations in the MSD site were
found in two proviruses. Full genome sequencing showed that
seven of the noninduced proviruses with J or MSD mutations
were otherwise intact. To determine whether these mutations
rendered noninduced proviruses defective, we reconstructed
three clones by genome synthesis as described later. The recon-
structed proviruses included two clones with short (8 bp and
16 bp) J deletions in packaging stem loop 2 and one with a
MSD site mutation (TGjGT / TGjGG). Although these clones
had intact ORFs, they did not replicate in healthy donor CD4+
lymphoblasts (Figure S3B) under conditions in which other re-
constructed proviruses replicated well (discussed later). Thus,
mutations in cis elements render otherwise intact proviruses
defective.
AB
Figure 2. Mapping of Large Internal
Deletions in Noninduced Proviruses
(A) Locations of deletions. Dark blue horizontal
bars: continuous sequencing reads interrupted by
deletions. White horizontal bars: deletions. Light
blue vertical bars, tat and rev ORFs. Gray vertical
bar: RRE element.
(B) Representative sequences at deletion junc-
tions. Short repeats (underlined) at the deletion
junctions suggest a single reverse transcriptase
jump due to copy choice recombination (San-
chez et al., 1997; Temin, 1993). Hypermutated
sequences (see Figure S2) were not analyzed for
deletions.
See also Figure S2 and Figure S3 for J deletions.A Significant Proportion of Noninduced Proviruses Are
Replication Competent
Of 213 noninduced proviruses, 25 (11.7%) had intact ORFs and
cis elements. When compared with induced proviruses from the
same patient, no known lethal mutations were seen. To deter-
mine whether these intact noninduced proviruses are replication
competent, we used the direct sequencing results to reconstruct
full-length noninduced proviral clones by de novo genome syn-
thesis (Figure 3A). This strategy avoids PCR and cloning-induced
errors. We reconstructed six noninduced proviruses from fourCell 155, 540–551,patients by inserting the synthesized
sequence into a plasmid carrying the
reference isolate NL4-3. Not captured in
our PCR strategy is a 108 bp segment of
the provirus, representing nucleotides
(nt) 565–672 (HXB2 coordinates). This
segment in the 50 untranslated region
includes part of U5 and the primer bind-
ing site (pbs) (Figure 3A). Although U5
deletions may not affect replication
competence (Vicenzi et al., 1994), we
took additional steps to make the recon-
structed clones fully patient derived,
without any NL4-3 sequence. We used
limiting dilution PCR to amplify the LTR-
gag region from cells in p24wells. Using
a 424 bp segment from the 50 U3-R-U5 re-
gion (HXB2 nt 140–564), we constructed
phylogenetic trees (Figure S4). Then, us-
ing site-directed mutagenesis, we cor-
rected the 108 bp segment from NL4-3
to the phylogenetically closest sequence
from the same patient (Figure 3A). This
process results in proviruses that are
100% patient derived and 98.2% equiva-
lent to specific proviruses present in vivo,
with the remaining 1.8% equivalent to a
very closely related provirus from the
same patient. Given the high sequence
conservation in the 108 bp segment (Fig-
ure S4), we estimated that the recon-
structed clones could differ from theparent clones by, at most, 3 nt, or 0.03% of the genome. For
each patient, we also reconstructed an induced viral clone
from a p24+ well.
It is striking that all six reconstructed noninduced proviruses
from four different patients showed replication fitness compara-
ble to that of the NL4-3 and reconstructed induced proviruses
from the same patients (Figure 3B). It is unlikely that all of these
intact noninduced proviruses could have actually been defective
with inactivating mutations in the 108 bp segment that was not
directly sequenced, as we showed that an additional round ofOctober 24, 2013 ª2013 Elsevier Inc. 543
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Figure 3. Growth Kinetics of Reconstructed
Noninduced Viruses
(A) Reconstruction of full-length noninduced pro-
viruses. Pink indicates clonal patient-derived
sequence. Blue indicates pNL4-3. Purple indicates
sequence from the most closely related patient-
specific virus.
(B) Growth kinetics of reconstructed noninduced
viruses from p24 wells (pink and purple), re-
constructed induced viruses from p24+ wells
(yellow), and NL4-3 (black). Data are presented as
mean ± SEM.
See also Figure S4.PHA stimulation causes some noninduced proviruses to
produce replication-competent virus (described later). Taken
together, these results indicate that a substantial fraction of
noninduced proviruses are intact and capable of generating
infectious virus if induced in vivo.
Noninduced Proviruses Have Intact Promoter Function
unless Hypermutated
The ability of intact noninduced proviruses to produce infectious
virus suggests that, at the primary sequence level, their pro-
moters are functional. To confirm this, we cloned long terminal
repeats (LTRs) from representative noninduced proviruses into
a luciferase reporter construct (Yang et al., 2009). We measured
luciferase activity in transfected resting CD4+ T cells before and
4 hr after stimulation with phorbol myristate acetate (PMA) and
ionomycin. We also analyzed LTRs from induced proviruses
from the same patients and NL4-3. In general, LTRs from nonin-
duced proviruses showed basal (Figures 4A and 4C) and stimu-544 Cell 155, 540–551, October 24, 2013 ª2013 Elsevier Inc.lated (Figures 4B and 4D) activity compa-
rable to LTRs from induced proviruses
and NL4-3. Decreased LTR function was
only observed for hypermutated clones.
This likely reflects G/ A hypermutation
in binding sites for the transcription fac-
tors NF-kB and Sp1 (Figure 4E). Thus,
most noninduced proviruses have LTRs
that are intact at the primary sequence
level.
Most Noninduced Proviruses Are
Integrated into Active Transcription
Units
We next determined the locations of non-
induced proviruses in the host genome to
understand whether they were integrated
into sites unfavorable for transcription.
Bushman et al. showed that HIV-1 typi-
cally integrates into transcription units
(as shown in Schro¨der et al., 2002). How-
ever, in some model systems, integration
into regions of heterochromatin is associ-
ated with latency (Jordan et al., 2003).
Using inverse PCR at limiting dilution,we found that 92.9% of 70 noninduced proviruses resided in
transcription units (Figure 5A), consistent with previous obser-
vations in patient resting CD4+ T cells (91%) (Han et al.,
2004). Based on transcript levels measured in a serial analysis
of gene expression (SAGE) library from a primary cell model of
latency (Shan et al., 2011), most noninduced proviruses were
integrated into genes transcribed at moderate levels in both
resting and activated CD4+ T cells (Figure 5B). Noninduced pro-
viruses were found in both orientations with respect to the host
genes (Figure 5C). Overall, these results indicate that nonin-
duced proviruses are not integrated into chromosomal regions
that are repressive for transcription; thus, other factors must
have prevented expression.
Lack of CpG Methylation in the LTR of Noninduced
Proviruses
We next examined whether noninduced proviruses were
silenced by CpG methylation. CpG islands are present in
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Figure 4. LTR Activity of Noninduced
Proviruses
LTR activity measured before, in (A) and (C), and
4 hr after PMA/ionomycin stimulation, in (B) and
(D). Resting CD4+ T cells were transfected with
LTR-firefly luciferase reporter constructs contain-
ing LTRs from noninduced proviruses or induced
proviruses from p24+ wells (yellow bars). Firefly
luciferase activity was normalized to an internal
control, Renilla luciferase driven by a constitutive
thymidine kinase promoter. The resulting values
were then expressed relative to the NL4-3 control.
Noninduced proviruses included those with intact
genomes (red bars), insertions or deletions (blue
bars), and hypermutation (white bars). Asterisks
indicate different clones with the same LTR
sequence. Data are presented as mean ± SEM.
(E) Impact of G/ A hypermutation on transcrip-
tion factor binding sites. Hypermutated sites in
representative clones are shaded.the HIV-1 genome (Cha´vez et al., 2011), including one in the
U3 region of the LTR, which contains critical transcription
factor binding sites (Figure 6). Therefore, DNA from freshly
isolated resting CD4+ T cells and from cells in p24 wells
was treated with bisulfite, and then the LTR region was ampli-
fied under limiting dilution conditions (Blazkova et al., 2012).
Direct sequencing was used to determine the extent of
CpG methylation. Only 3.1% of the LTR CpGs were methyl-
ated in resting CD4+ T cells from study patients. Even fewer
(0.9%) of the CpGs in the LTRs of noninduced proviruses
were methylated (Figure 6). In contrast, we readily detected
methylation at a CpG island in the env region (75.5%), indi-
cating that this method did not selectively amplify nonme-
thylated sites. Although CpG methylation at the LTR clearly
is well documented in some models of HIV-1 latency
(Kauder et al., 2009), our results indicate that noninduced
proviruses are not silenced through CpG methylation at the
50 LTR.Cell 155, 540–551,Intact Noninduced Proviruses May
Increase LR Size by 60-Fold
The aforementioned results indicate that
although most noninduced proviruses
have identifiable lethal defects, a sub-
stantial fraction are intact and replication
competent at the primary sequence level.
Analysis of LTR function, integration sites,
and methylation status suggests that
these intact noninduced proviruses could
be induced in vivo, thereby increasing
LR size. We compared the frequency of
induced proviruses (defined using the
VOA) and intact noninduced proviruses
(quantitated as the product of total
proviral DNA frequency and the frac-
tion of noninduced proviruses that are
intact) among the total pool of provi-
ruses (measured by quantitative PCR).Bayesian analysis was chosen instead of maximum likelihood
estimation because the former provides nonzero point estimates
for patients from whom no clones with intact genomes were
identified. The positive VOA results in every patient and the suc-
cessful detection of intact noninduced proviruses in patients for
whom >20 clones were analyzed suggest that intact noninduced
proviruses could be detected in every patient if enough clones
are examined. The fraction of intact noninduced proviruses
was calculated as themedian of an empirical Bayesian posterior,
the most conservative of five models tested (Table S3), with a
prior distribution chosen to reflect the observed data. Both the
fraction of intact noninduced proviruses and the total number
of proviruses per 106 resting CD4+ T cells varied dramatically
from patient to patient (Figure 7A). There was no correlation be-
tween the VOA and the frequency of intact noninduced provi-
ruses (Figure 7B). All statistical models (Table S3) indicated
that the median frequency of intact noninduced proviruses was
at least60-fold higher than the frequency of induced provirusesOctober 24, 2013 ª2013 Elsevier Inc. 545
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Figure 5. Integration Sites of Noninduced
Proviruses
(A) Distribution of integration sites of noninduced
proviruses. Intron and exon boundaries are
determined as described elsewhere (Shan et al.,
2011).
(B) Transcription level of host genes in which
noninduced proviruses were integrated. Tran-
scription levels were determined by SAGE analysis
of Bcl-2 transduced, activated and resting primary
CD4+ T cells as described elsewhere (Shan et al.,
2011). Blue circles indicate transcript levels in
resting and activated CD4+ T cells. Red squares
indicate transcript levels for the subset of genes in
which integration sites of noninduced proviruses
were mapped.
(C) Transcriptional orientation of noninduced pro-
viruses relative to the host gene.detected in the VOA. If the intact noninduced proviruses
described here can be induced in vivo, then the size of the LR
is much greater than previously thought (Figure 7C).
To determine whether intact noninduced proviruses are
permanently silenced or potentially inducible under certain con-
ditions, we tested whether repeated PHA stimulation could
induce additional noninduced proviruses (Figure S5). We stimu-
lated multiple replicate cultures of 2 3 105 patient resting CD4+
T cells with PHA in VOA conditions. We then split each culture
well equally into two wells on day 7. As all patient cells have
divided by day 7 (Figure S1), each split well contained daughter
cells derived from cells activated in the original well. One set of
the ‘‘split-culture’’ wells was activated again with PHA, while
the other set was cultured without additional stimulation. We
then compared supernatant p24 levels after another 14 days of
culture. Among 126 p24 wells from four patients, 31 (24.6%)
became p24+ after the additional round of PHA stimulation, while
the paired-culture well that did not receive an additional round
of stimulation remained p24 (Figure 7D). It is not yet clear
what fraction of the intact noninduced proviruses are inducible
in vivo. Nevertheless, these results demonstrate that at least
some intact noninduced proviruses can be induced under
repeated stimulation.
DISCUSSION
The LR in resting CD4+ T cells is the major barrier to HIV-1 erad-
ication, and as efforts to cure the infection proceed, accurate546 Cell 155, 540–551, October 24, 2013 ª2013 Elsevier Inc.measurement of LR size will be essential.
This study provides a molecular basis for
understanding measures of the LR.
Through an analysis of proviruses that
did not give rise to infectious virus
following a single round of T cell activation
(noninduced proviruses), we have pro-
vided a definitive explanation for the large
discrepancy between results of PCR and
culture assays of LR size. In addition,
the identification of intact noninducedproviruses indicates that the size of the LR may be much greater
than previously thought. We reconstructed full-length, intact
noninduced proviruses from multiple patients, and all showed
growth kinetics comparable to induced proviruses from the
same patient and a reference isolate. These intact noninduced
proviruses are not detected in standard culture assays but may
nevertheless prevent cure. Thus, the present study provides in-
sights into the extent of the challenge posed by the LR and
may lead to novel strategies that target intact noninduced
proviruses.
Weshowhere thatmost noninducedproviruseswere rendered
defective during reverse transcription by APOBEC3G-induced
hypermutation (Yu et al., 2004), by internal deletions caused by
copy choice recombination during reverse transcription (San-
chez et al., 1997), or by frame-shift or nonsense mutations
caused by the error-prone reverse transcriptase (Bebenek
et al., 1989). The resulting defective viral genomes can still
integrate because only defects at the ends of the genome affect
integration. Thedefective genomeswill bedetected inmostPCR-
based assays of proviral DNA, provided that the primer binding
sites are intact.Many of the defective proviruses have large inter-
nal deletions encompassing the Tat and Rev ORFs and the RRE.
Tat-mediated transactivation is required for effective transcrip-
tional elongation (Kao et al., 1987), and the production of virus
particles requires that singly spliced and unsplicedHIV-1mRNAs
be exported from the nucleus in a Rev-dependent fashion (Malim
et al., 1989). Thus, thesedeletedprovirusesmaynot produce viral
proteins, even after successful induction of transcription. The
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Figure 6. CpG Methylation of Noninduced
Proviruses
(A) Positions of CpGs analyzed.
(B) CpG methylation in the 50 LTR of proviruses in
resting CD4+ T cells from the indicated patients.
Each row represents a single provirus amplified by
limiting dilution PCR after bisulfite treatment. Open
circles indicate nonmethylated CpGs. Closed cir-
cles indicate methylated CpGs. Missing circles
indicate no CpG present due to sequence poly-
morphism.
(C) CpG methylation in the env gene of proviruses
from resting CD4+ T cells.
(D) CpG methylation in the 50 LTR of noninduced
proviruses from p24 wells.
(E) CpGmethylation in the env gene of noninduced
proviruses from p24 wells.same is true for hypermutated proviruses, which have stop
codons in every ORF. Of note, eradication strategies depend
on the production of viral proteins, which allows recognition of
the infected cells byHIV-1 specificCTL (Shanet al., 2012). Defec-
tive proviruses with large internal deletions and/or APOBEC3G-
induced hypermutationmay not be eliminated even by strategies
that effectively eliminate cells carrying replication-competent
virus. These considerations highlight the difficulty of assessing
eradication strategies with PCR-based assays.
Although difficult and time consuming, the VOA (Eriksson
et al., 2013; Finzi et al., 1997), which has recently been simplified
(Laird et al., 2013), does allow detection of cells harboring repli-
cation-competent virus. However, the identification of intact,
noninduced proviruses raises the possibility that this assay
may dramatically underestimate LR size. Several lines of evi-
dence suggest that this is not simply an issue of assay sensitivity.
We showed that the PHA stimulation activates all resting CD4+
T cells as assessed by proliferation and activation markerCell 155, 540–551,expression. Using prolonged culture and
sensitive RT-PCR assays, we also verified
that wells from which noninduced provi-
ruses were obtained were truly negative
for viral outgrowth. It is also unlikely that
these p24 wells remained negative
because of reduced viral fitness, as we
showed that intact noninduced provi-
ruses had growth kinetics comparable
to induced viruses from p24+wells. Taken
together, these results confirm that we
are examining a population of intact pro-
viruses that were not induced to produce
infectious virus after a single round of
maximum in vitro activation.
To prove replication competence, we
reconstructed six intact, noninduced
proviruses from six different p24 wells
from four patients. Surprisingly, all recon-
structed viruses replicated as well as the
standard reference isolate and control
viruses reconstructed from p24+ wells. Asterilizing cure requires elimination of all replication-competent
HIV-1; therefore, the discovery that intact noninduced proviruses
are replication competent means that the number of proviruses
that must be eliminated is much higher than previously thought.
We conservatively estimate that the number may be 60-fold
higher than estimates based on the VOA. Some statistical
models suggest an even higher number (medians of 97–273-
fold). Of note, there is large interpatient variation in this and other
measures of LR size. Overall, our results indicate that the ‘‘shock
and kill’’ strategy (Archin et al., 2012; Deeks, 2012) is challenged
with a large but unmeasured hidden population of replication-
competent proviruses. It is interesting that, despite the intense
search for novel latency reversing agents, none of the drugs
tested to date reaches the robust level of in vitro HIV-1 induction
achieved by PHA. Thus, the finding that the true size of the LR
may be 60-fold greater than that estimated using PHA activa-
tion is particularly disturbing. However, it is also important to
point out that even a low level of virus gene expression may beOctober 24, 2013 ª2013 Elsevier Inc. 547
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Figure 7. Quantification of Intact Nonin-
duced Proviruses
(A) Comparison of the frequency of cells detected
in the VOA, cells carrying intact noninduced
proviruses, and cells carrying HIV-1 DNA. The
frequency of cells with HIV-1 DNA was measured
by quantitative PCR on freshly isolated resting
CD4+ T cells. The frequency of cells with intact,
noninduced proviruses was calculated as fre-
quency of cells with HIV-1 DNA times the
proportion of intact noninduced proviruses
estimated for each patient using an empirical
Bayesian model (Table S3). Open symbols indi-
cate no intact proviruses detected, and empirical
Bayesian estimate plotted. Bars indicate median
value.
(B) Correlation between the frequency of cells
detected in the VOA and the frequency of cells
with intact noninduced proviruses. Open symbols,
see (A).
(C) Scale representation of the frequencies of
the infected resting CD4+ T cell populations.
Volume reflects population size. Yellow circles
indicate minimum size of the LR as measured
by VOA. Magenta indicates frequency of cells
with intact proviruses. This is the potential size
of the LR if intact noninduced proviruses can
be induced in vivo. Blue indicates cells with
HIV-1 DNA.
(D) Repeated stimulation induces additional pro-
viruses. Bars indicate p24 ELISA results from pairs
of split wells cultured with or without a second
round of stimulation with PHA and irradiated allo-
geneic PBMC.
See also Figure S5 and Table S3.sufficient to allow the elimination of infected cells by an appropri-
ately primed CTL response (Shan et al., 2012) and that the critical
variable may be the fraction of latently infected cells induced to
express HIV-1 genes.
Understanding why intact noninduced proviruses did not pro-
duce infectious virus after maximum in vitro T cell activation is
critical for determining their clinical significance. Possible expla-
nations include silencing by repressive chromatin modifications
or transcriptional interference. We analyzed CpG methylation of
the LTRs of noninduced proviruses at the clonal level. In contrast
to some in vitro models of HIV-1 latency (Kauder et al., 2009), we
found that in patient CD4+ T cells there was little CpG methyl-
ation at the LTR, consistent with another recent study (Blazkova
et al., 2012). We also examined whether noninduced proviruses
are silenced by integration into heterochromatin. We found that
most of the noninduced proviruses were integrated into active
transcription units, consistent with previous studies showing
that most HIV-1 proviruses are integrated into introns of actively
transcribed genes in cell lines (Schro¨der et al., 2002) and patient548 Cell 155, 540–551, October 24, 2013 ª2013 Elsevier Inc.resting CD4+ T cells (Han et al., 2004).
Another potential explanation for the non-
induced proviruses is transcriptional
interference (Han et al., 2008; Lenasi
et al., 2008). Since T cell activation mayovercome transcriptional interference due to the high affinity of
NF-kB for its binding sites in the LTR (Lenasi et al., 2008), tran-
scriptional interference may not be a major cause of silencing
of the noninduced proviruses.
We propose that, despite maximum T cell activation, the in-
duction of latent proviruses is stochastic. Cellular gene expres-
sion levels may follow a digital or analog distribution after T cell
receptor activation, as a result of stochastic and dynamic pro-
cesses (Chakraborty and Das, 2010). Elegant experimental and
theoretical studies have shown that HIV-1 proviruses may
show stochastic fluctuations in expression depending on levels
of Tat (Burnett et al., 2009; Singh et al., 2010; Weinberger
et al., 2005; Weinberger et al., 2008). We propose that intact pro-
viruses undergo stochastic induction even after maximum
cellular activation. Some will be induced by one round of activa-
tion, while others will remain silent but retain the potential to be
activated subsequently. These results indicate an increased bar-
rier to cure, as all intact noninduced proviruses need to be erad-
icated. Underestimation of intact proviruses by VOAs could be
reflected in delayed viral rebound after an apparent ‘‘cure,’’ and
overestimation of LR size resulting from detection of defective
proviruses by PCR assays could result in prolonged, excessive
exposure to toxic latency reversing agents. Thus, the molecular
analysis of noninduced proviruses contributes in an important
way to HIV-1 eradication efforts.
EXPERIMENTAL PROCEDURES
Study Subjects
Peripheral blood was obtained from healthy volunteers and infected donors
who had suppression of viremia to <50 copies HIV-1 RNA/ml for >6 months
on ART. This study was approved by the Johns Hopkins Institutional Review
Board. Written informed consent was obtained from all participants.
VOA
VOAs were performed as described elsewhere (Finzi et al., 1997; Siliciano and
Siliciano, 2005), except that patient cells and donor lymphoblasts were placed
in separate chambers in transwell plates. CD8-depleted donor lymphoblasts
were added on days 1, 7, and 14. Culture supernatants were examined for
p24 by ELISA (PerkinElmer) after 21 days.
Characterization of Full-Length Noninduced Proviruses
Genomic DNA isolated from p24wells seeded with 43 104 or 23 105 patient
resting CD4+ T cells was subjected to limiting dilution prior to amplification with
an initial near-full-genome length outer PCR (U5 to U5), followed nested ampli-
fication of a segment of the gag gene. Aliquots from clonal (p > 0.9) positive
outer PCR wells were subjected to four inner PCRs to obtain near full-length
genome sequence. The procedures are described in Extended Experimental
Procedures. PCR conditions are listed in Table S2. PCR products were directly
sequenced. Sequences of 213 noninduced clones and 7 induced clones were
submitted to GenBank (accession numbers KF526120-KF526339).
Reconstruction of Noninduced Proviruses
The reconstruction of full-length noninduced proviruses is described in
Extended Experimental Procedures. Reconstructed plasmids were checked
by restriction digestion and sequencing and then transfected into HEK293T
cells for virus production. The virus-containing supernatants were adjusted
to 200 ng/ml of p24 and used to infect healthy donor CD4+ T lymphoblasts
for analysis of growth kinetics.
Measurement of LTR Function
Patient-derived LTR sequences were cloned into the wt-LTR-Luc reporter and
transfected into resting CD4+ T cells from healthy donors using nucleofection
(Amaxa) (Yang et al., 2009). TK-RLuc was used as internal control. After 48 hr,
basal luciferase activity was measured. We also measured luciferase activity
4 hr after stimulation with PMA (10 ng/ml) and ionomycin (1 mM).
Integration Site, CpG Methylation, and Quantitative RT-PCR
Integration site analysiswas carried out by inversePCRasdescribed elsewhere
(Han et al., 2004). Transcription levels of the host genes containing integration
sites were determined using a previously described SAGE analysis of Bcl-2-
transduced primary resting and activated CD4+ T cells (Shan et al., 2011).
CpG methylation analysis was carried out as described by Blazkova et al.
(2012). Total proviral DNA in resting CD4+ T cells was quantified using an RT-
PCR assay (Durand et al., 2012). Copy numbers of the human RNaseP gene
copies were measured in separate reactions to quantify cell number (TaqMan
Copy Number Reference Assay, RNaseP, Invitrogen) (Spivak et al., 2011).
Statistical Analysis
Activation marker expression, viral outgrowth, and LTR function were
compared by two-tailed Student’s t test for independent samples. The corre-
lation between viral outgrowth and intact noninduced provirus frequency was
analyzed using MedCalc software. Bayesian inference was used to estimate
the proportion of intact noninduced genomes in each patient. An empirical
Bayesian prior, among five models (Table S3; Extended Experimental Proce-dures), was chosen to reflect the distribution of the observed data. These pro-
portions weremultiplied by total HIV-1 DNA copies per 106 resting CD4+ T cells
to yield an estimate of intact noninduced proviruses per 106 cells.
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